These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26425837)

  • 1. PTPRD gene associated with blood pressure response to atenolol and resistant hypertension.
    Gong Y; McDonough CW; Beitelshees AL; El Rouby N; Hiltunen TP; O'Connell JR; Padmanabhan S; Langaee TY; Hall K; Schmidt SO; Curry RW; Gums JG; Donner KM; Kontula KK; Bailey KR; Boerwinkle E; Takahashi A; Tanaka T; Kubo M; Chapman AB; Turner ST; Pepine CJ; Cooper-DeHoff RM; Johnson JA
    J Hypertens; 2015 Nov; 33(11):2278-85. PubMed ID: 26425837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.
    Gong Y; McDonough CW; Wang Z; Hou W; Cooper-DeHoff RM; Langaee TY; Beitelshees AL; Chapman AB; Gums JG; Bailey KR; Boerwinkle E; Turner ST; Johnson JA
    Circ Cardiovasc Genet; 2012 Dec; 5(6):686-91. PubMed ID: 23087401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.
    Magvanjav O; Gong Y; McDonough CW; Chapman AB; Turner ST; Gums JG; Bailey KR; Boerwinkle E; Beitelshees AL; Tanaka T; Kubo M; Pepine CJ; Cooper-DeHoff RM; Johnson JA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.
    Vandell AG; Lobmeyer MT; Gawronski BE; Langaee TY; Gong Y; Gums JG; Beitelshees AL; Turner ST; Chapman AB; Cooper-DeHoff RM; Bailey KR; Boerwinkle E; Pepine CJ; Liggett SB; Johnson JA
    Hypertension; 2012 Oct; 60(4):957-64. PubMed ID: 22949529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses).
    McDonough CW; Magvanjav O; Sá ACC; El Rouby NM; Dave C; Deitchman AN; Kawaguchi-Suzuki M; Mei W; Shen Y; Singh RSP; Solayman M; Bailey KR; Boerwinkle E; Chapman AB; Gums JG; Webb A; Scherer SE; Sadee W; Turner ST; Cooper-DeHoff RM; Gong Y; Johnson JA
    Circ Genom Precis Med; 2018 Apr; 11(4):e001854. PubMed ID: 29650764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-Wide Meta-Analysis of Blood Pressure Response to β
    Singh S; Warren HR; Hiltunen TP; McDonough CW; El Rouby N; Salvi E; Wang Z; Garofalidou T; Fyhrquist F; Kontula KK; Glorioso V; Zaninello R; Glorioso N; Pepine CJ; Munroe PB; Turner ST; Chapman AB; Boerwinkle E; Johnson JA; Gong Y; Cooper-DeHoff RM
    J Am Heart Assoc; 2019 Aug; 8(16):e013115. PubMed ID: 31423876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atenolol induced HDL-C change in the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.
    McDonough CW; Gillis NK; Alsultan A; Chang SW; Kawaguchi-Suzuki M; Lang JE; Shahin MH; Buford TW; El Rouby NM; Sá AC; Langaee TY; Gums JG; Chapman AB; Cooper-DeHoff RM; Turner ST; Gong Y; Johnson JA
    PLoS One; 2013; 8(10):e76984. PubMed ID: 24116192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Night blood pressure responses to atenolol and hydrochlorothiazide in black and white patients with essential hypertension.
    Chapman AB; Cotsonis G; Parekh V; Schwartz GL; Gong Y; Bailey KR; Turner ST; Gums JG; Beitelshees AL; Cooper-DeHoff R; Boerwinkle E; Johnson JA
    Am J Hypertens; 2014 Apr; 27(4):546-54. PubMed ID: 23886594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomic Genome-Wide Meta-Analysis of Blood Pressure Response to β-Blockers in Hypertensive African Americans.
    Gong Y; Wang Z; Beitelshees AL; McDonough CW; Langaee TY; Hall K; Schmidt SO; Curry RW; Gums JG; Bailey KR; Boerwinkle E; Chapman AB; Turner ST; Cooper-DeHoff RM; Johnson JA
    Hypertension; 2016 Mar; 67(3):556-63. PubMed ID: 26729753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide.
    Turner ST; Boerwinkle E; O'Connell JR; Bailey KR; Gong Y; Chapman AB; McDonough CW; Beitelshees AL; Schwartz GL; Gums JG; Padmanabhan S; Hiltunen TP; Citterio L; Donner KM; Hedner T; Lanzani C; Melander O; Saarela J; Ripatti S; Wahlstrand B; Manunta P; Kontula K; Dominiczak AF; Cooper-DeHoff RM; Johnson JA
    Hypertension; 2013 Aug; 62(2):391-7. PubMed ID: 23753411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome Wide Analysis Approach Suggests Chromosome 2 Locus to be Associated with Thiazide and Thiazide Like-Diuretics Blood Pressure Response.
    Singh S; McDonough CW; Gong Y; Bailey KR; Boerwinkle E; Chapman AB; Gums JG; Turner ST; Cooper-DeHoff RM; Johnson JA
    Sci Rep; 2019 Nov; 9(1):17323. PubMed ID: 31754133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Wide Association Approach Identified Novel Genetic Predictors of Heart Rate Response to β-Blockers.
    Shahin MH; Conrado DJ; Gonzalez D; Gong Y; Lobmeyer MT; Beitelshees AL; Boerwinkle E; Gums JG; Chapman A; Turner ST; Cooper-DeHoff RM; Johnson JA
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugs.
    Hiltunen TP; Donner KM; Sarin AP; Saarela J; Ripatti S; Chapman AB; Gums JG; Gong Y; Cooper-DeHoff RM; Frau F; Glorioso V; Zaninello R; Salvi E; Glorioso N; Boerwinkle E; Turner ST; Johnson JA; Kontula KK
    J Am Heart Assoc; 2015 Jan; 4(1):e001521. PubMed ID: 25622599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-Wide Association Study of Apparent Treatment-Resistant Hypertension in the CHARGE Consortium: The CHARGE Pharmacogenetics Working Group.
    Irvin MR; Sitlani CM; Floyd JS; Psaty BM; Bis JC; Wiggins KL; Whitsel EA; Sturmer T; Stewart J; Raffield L; Sun F; Liu CT; Xu H; Cupples AL; Tanner RM; Rossing P; Smith A; Zilhão NR; Launer LJ; Noordam R; Rotter JI; Yao J; Li X; Guo X; Limdi N; Sundaresan A; Lange L; Correa A; Stott DJ; Ford I; Jukema JW; Gudnason V; Mook-Kanamori DO; Trompet S; Palmas W; Warren HR; Hellwege JN; Giri A; O'donnell C; Hung AM; Edwards TL; Ahluwalia TS; Arnett DK; Avery CL
    Am J Hypertens; 2019 Nov; 32(12):1146-1153. PubMed ID: 31545351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies.
    McDonough CW; Warren HR; Jack JR; Motsinger-Reif AA; Armstrong ND; Bis JC; House JS; Singh S; El Rouby NM; Gong Y; Mychaleckyj JC; Rotroff DM; Benavente OR; Caulfield MJ; Doria A; Pepine CJ; Psaty BM; Glorioso V; Glorioso N; Hiltunen TP; Kontula KK; Arnett DK; Buse JB; Irvin MR; Johnson JA; Munroe PB; Wagner MJ; Cooper-DeHoff RM
    Clin Pharmacol Ther; 2021 Sep; 110(3):723-732. PubMed ID: 34231218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PROX1 gene variant is associated with fasting glucose change after antihypertensive treatment.
    Gong Y; McDonough CW; Beitelshees AL; Karnes JH; O'Connell JR; Turner ST; Chapman AB; Gums JG; Bailey KR; Boerwinkle E; Johnson JA; Cooper-DeHoff RM
    Pharmacotherapy; 2014 Feb; 34(2):123-30. PubMed ID: 24122840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patients.
    Lobmeyer MT; Wang L; Zineh I; Turner ST; Gums JG; Chapman AB; Cooper-DeHoff RM; Beitelshees AL; Bailey KR; Boerwinkle E; Pepine CJ; Johnson JA
    Pharmacogenet Genomics; 2011 Jan; 21(1):42-9. PubMed ID: 21127457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control.
    Holzgreve H; Nakov R; Beck K; Janka HU
    Am J Hypertens; 2003 May; 16(5 Pt 1):381-6. PubMed ID: 12745200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrochlorothiazide and atenolol combination antihypertensive therapy: effects of drug initiation order.
    Johnson JA; Gong Y; Bailey KR; Cooper-DeHoff RM; Chapman AB; Turner ST; Schwartz GL; Campbell K; Schmidt S; Beitelshees AL; Boerwinkle E; Gums JG
    Clin Pharmacol Ther; 2009 Nov; 86(5):533-9. PubMed ID: 19571804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.